Semanteon Capital Management LP purchased a new position in Ceridian HCM Holding Inc. (NYSE:CDAY – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 6,248 shares of the company’s stock, valued at approximately $419,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of CDAY. CWM LLC grew its position in Ceridian HCM by 5.4% in the 3rd quarter. CWM LLC now owns 3,268 shares of the company’s stock worth $222,000 after purchasing an additional 167 shares during the last quarter. Czech National Bank lifted its holdings in shares of Ceridian HCM by 48.2% during the 3rd quarter. Czech National Bank now owns 27,197 shares of the company’s stock worth $1,845,000 after acquiring an additional 8,845 shares during the period. Asset Management One Co. Ltd. lifted its holdings in shares of Ceridian HCM by 4.8% during the 3rd quarter. Asset Management One Co. Ltd. now owns 60,615 shares of the company’s stock worth $4,113,000 after acquiring an additional 2,790 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its holdings in shares of Ceridian HCM by 17.1% during the 3rd quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 39,131 shares of the company’s stock worth $2,655,000 after acquiring an additional 5,700 shares during the period. Finally, Cambridge Investment Research Advisors Inc. lifted its holdings in shares of Ceridian HCM by 22.1% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 54,047 shares of the company’s stock worth $3,667,000 after acquiring an additional 9,766 shares during the period.
Analyst Upgrades and Downgrades
CDAY has been the subject of a number of analyst reports. Robert W. Baird reaffirmed an “outperform” rating and set a $86.00 price objective on shares of Ceridian HCM in a report on Friday, January 19th. Stifel Nicolaus initiated coverage on shares of Ceridian HCM in a report on Wednesday, January 10th. They set a “buy” rating and a $75.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $76.38.
Ceridian HCM Price Performance
CDAY stock traded down $0.12 during trading on Friday, hitting $59.58. 1,197,945 shares of the stock traded hands, compared to its average volume of 1,312,424. Ceridian HCM Holding Inc. has a one year low of $55.62 and a one year high of $79.66. The stock has a market cap of $9.30 billion, a price-to-earnings ratio of 1,986.00, a P/E/G ratio of 2.12 and a beta of 1.38. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.53. The company has a 50 day simple moving average of $66.08 and a 200 day simple moving average of $67.35.
Ceridian HCM Profile
Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources, payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.
Recommended Stories
- Five stocks we like better than Ceridian HCM
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Stocks Leading the U.S. Agriculture Comeback
- What does consumer price index measure?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Stock Analyst Ratings and Canadian Analyst Ratings
- Alphabet Changes the Narrative with Its First-Ever Dividend
Want to see what other hedge funds are holding CDAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ceridian HCM Holding Inc. (NYSE:CDAY – Free Report).
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.